FDA approves first generic versions of Boniva
On March 19, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Boniva (ibandronate) tablets, used to treat osteoporosis. Read…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.